✦ LIBER ✦

Autologous Hematopoietic Stem Cell Transplant (aHSCT) is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)

✍ Scribed by Pandit, Akshata; Wei, Lai; Elder, Patrick; Falk, William; Sell, Megan; Hofmeister, Craig C.; Benson, Don M.; Penza, Sam; Andritsos, Leslie A.; Klisovic, Rebecca; Vasu, Sumithira; Blum, William; Devine, Steven M.; Jaglowski, Samantha; Efebera, Yvonne

Book ID: 122420931
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 69 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary Systemic Amyloidosis Presenting

Primary Systemic Amyloidosis Presenting as a Colonic Stricture: Successful Treatment with Left Hemicolectomy Followed by Autologous Hematopoietic Stem-Cell Transplantation

✍ S. Rives; M. Pera; L. Rosiñol; O. Vidal; R. Miquel; M. Solé; J. García-Valdecasa 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 392 KB

Early intensification and autologous ste

Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience

✍ Valérie Frossard; Nicolas Ketterer; Anne Rosselet; Pascal Meier; Anne Cairoli; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 116 KB

High-Dose Therapy and Autologous Hematop

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation for Patients With Primary Systemic Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

✍ Vesole, David H.; Pérez, Waleska S.; Akasheh, Marwan; Boudreau, Christian; Reece 📂 Article 📅 2006 🏛 Mayo Clinic 🌐 English ⚖ 83 KB

Renal Response After High-Dose Melphalan

Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis

✍ Nelson Leung; Angela Dispenzieri; Fernando C. Fervenza; Martha Q. Lacy; Rafael V 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Induction therapy with bortezomib and de

Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

✍ Huang, Xianghua; Wang, Qingwen; Chen, Wencui; Zeng, Caihong; Chen, Zhaohong; Gon 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 278 KB

Treatment-Related Mortality in Patients

✍ V. Sanchorawala; M. Skinner; K.T. Finn; K. Quillen; D.C. Seldin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB